MedTrace Logo

The Study of Koebner in Patients With Psoriasis and Psoriatic Arthritis

NCT05589298 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3064

Last updated 2024-12-04

No results posted yet for this study

Summary

PSODEEP 1 is a descriptive digital interview study where we intend to include at least 900 individuals. Individuals with known psoriasis or known psoriatic arthritis will access the digital interview via a QR code distributed via their rheumatology or dermatology department using their smartphones. Data on answers results are stored digitally and can be accessed parallel to recruitment. Questions focus on following fields (all self reported): background information (age/sex), disease duration, disease course/fluctuation, disease diagnosis as given by MD, disease treatment, disease severity, disease classification, disease triggers, screening of psoriatic arthritis (questions derived from PEST questionnaire), Koebner occurence, variability in Koebner over time, deep-Koebner occurence and variability in Deep-Koebner over time.

Conditions

  • Psoriasis
  • Psoriasis; Arthritis (Etiology)
  • Koebner Phenomenon

Sponsors & Collaborators

  • University of Chile

    collaborator OTHER

  • University of Copenhagen

    collaborator OTHER

  • Karolinska Institutet

    collaborator OTHER

  • Lund University

    collaborator OTHER

  • Skane University Hospital

    lead OTHER

Principal Investigators

  • Albert Duvetorp, MD PhD · Lunds University, Copenhagen University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-19
Primary Completion
2024-02-14
Completion
2024-02-14

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05589298 on ClinicalTrials.gov